Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kleyman, T. R.
space
  arrow  Ling, B. N.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

A Mechanism for Pentamidine-Induced Hyperkalemia: Inhibition of Distal Nephron Sodium Transport

right arrow Thomas R. Kleyman; Camille Roberts; and Brian N. Ling

15 January 1995 | Volume 122 Issue 2 | Pages 103-106

Objectives: To determine whether pentamidine directly affects the transport of renal ions and thus provides a mechanism for hyperkalemia, which develops in as many as 100% of patients with the acquired immunodeficiency syndrome (AIDS) who receive pentamidine for more than 6 days.

Design: Transepithelial and single-channel electrical measurements were made on two models of distal-nephron ion transport: an amphibian distal-nephron cell line (A6) and primary cultures of rabbit cortical collecting tubules.

Results: Luminal bath application of pentamidine to A6 monolayers inhibited the amiloride-sensitive, short-circuit current with a 50% inhibitory concentration of 700 µmolars (five experiments). In the principal cell apical membranes of cortical collecting tubule primary cultures, amiloride-sensitive, 4-picosiemen Na+ channels in cell-attached patches were also identified. When the luminal membrane was directly exposed to 1.0 µmolars of pentamidine in the patch pipette solution, channel activity decreased by 40% (11 experiments). Channel inhibition rapidly reversed with washout of intrapipette pentamidine (four experiments). In contrast, replacement of either the luminal bath outside the patch pipette (four experiments) or the serosal bath (five experiments) with pentamidine did not significantly affect Na+ channel activity in the patches.

Conclusions: Luminal or "urinary" pentamidine inhibits distal nephron reabsorption of Na+ by blocking apical Na+ channels in a manner similar to "potassium-sparing" diuretics (for example, amiloride and triamterene). This results in a decrease in the electrochemical gradients that drive secretion of distal nephron K+. Because pentamidine is eliminated through urinary excretion, this renal tubular effect provides a mechanism for pentamidine-induced hyperkalemia.

Author and Article Information
space

From the University of Pennsylvania School of Medicine and Veterans Affairs Medical Center, Philadelphia, Pennsylvania, and Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, Georgia.
Requests for Reprints: Brian N. Ling, MD, Emory University School of Medicine, Renal Division, 1364 Clifton Road Northeast, Atlanta, GA 30322.
Acknowledgments: The authors thank Allyson Morrison and Elisabeth E. Seal for their technical assistance in preparing and maintaining the A6 cell cultures and rabbit cortical collecting tubule primary cultures.
Grant Support: By a Veterans Affairs Merit Review Award, an American Heart Association Established Investigator Award, a Grant-in-Aid Award, a grant from the Center for Excellence Program, a National Institutes of Health Clinical Investigator Award (K08-DK02111), and an Emory University Research Committee Award.




This article has been cited by other articles:


Home page
NEJMHome page
B. F. Palmer
Managing Hyperkalemia Caused by Inhibitors of the Renin-Angiotensin-Aldosterone System
N. Engl. J. Med., August 5, 2004; 351(6): 585 - 592.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
N. R. Poola, M. Kalis, F. M. Plakogiannis, and D. R. Taft
Characterization of pentamidine excretion in the isolated perfused rat kidney
J. Antimicrob. Chemother., September 1, 2003; 52(3): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. W. Stead, P. G. Bray, I. G. Edwards, H. P. DeKoning, B. C. Elford, P. A. Stocks, and S. A. Ward
Diamidine Compounds: Selective Uptake and Targeting in Plasmodium falciparum
Mol. Pharmacol., April 16, 2001; 59(5): 1298 - 1306.
[Abstract] [Full Text]


Home page
Postgrad. Med. J.Home page
P Patel, B Mandal, and M W Greenway
Hyperkalaemic quadriparesis secondary to chronic diclofenac treatment
Postgrad. Med. J., January 1, 2001; 77(903): 50 - 51.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
R. F. Reilly and D. H. Ellison
Mammalian Distal Tubule: Physiology, Pathophysiology, and Molecular Anatomy
Physiol Rev, January 1, 2000; 80(1): 277 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kieber-Emmons, C. Lin, M. H. Foster, and T. R. Kleyman
Antiidiotypic Antibody Recognizes an Amiloride Binding Domain within the alpha  Subunit of the Epithelial Na+ Channel
J. Biol. Chem., April 2, 1999; 274(14): 9648 - 9655.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1995 by the American College of Physicians.